Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

124 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Eligibility Head and Neck Cancer NCT02124707

- 02.02.20 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN; ODM derived from: https://clinicaltrials.gov/show/NCT02124707

Eligibility Head and Neck Cancer NCT00670397

- 02.02.20 - 1 Formular, 1 Itemgruppe, 19 Datenelemente, 1 Sprache
Itemgruppe: Criteria
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00670397

Eligibility Head and Neck Cancer NCT02442739

- 02.04.19 - 1 Formular, 2 Itemgruppen, 22 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Safety Study of Ketamine for Preventing Depression in Patients Undergoing Treatment for Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02442739

Eligibility Head and Neck Cancer NCT02410382

- 01.04.19 - 1 Formular, 2 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02410382

Eligibility Cancer of the Head and Neck NCT00180921

- 21.07.16 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT00180921

Eligibility Head and Neck Cancer NCT01958515

- 31.08.15 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation; ODM derived from: https://clinicaltrials.gov/show/NCT01958515

dbGaP phs001202 OncoArray: Oral and Pharynx Cancer - pht005773.v1.p1

- 22.05.23 - 5 Formulare, 1 Itemgruppe, 5 Datenelemente, 1 Sprache
Itemgruppe: pht005773
Principal Investigator: Paul Brennan, PhD, International Agency for Research on Cancer (IARC), Lyon, France MeSH: Head and Neck Neoplasms,Mouth Neoplasms,Pharyngeal Neoplasms,Oropharyngeal Neoplasms,Hypopharyngeal Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001202 Genetic factors play an important role in susceptibility to head and neck cancer and could also explain differences in response to treatment and outcome. The goal of this project is to investigate genetic variation involved in oral and oropharyngeal cancer susceptibility by performing the largest GWAS on these diseases, using a novel genotyping tool specifically designed for cancer studies by the OncoArray Network. This project encompasses data from approximately 6000 oral and pharynx cancer cases and 4000 controls derived from 12 epidemiological studies most of case-control design. The genotyping was centralized at the Center for Inherited Disease Research (CIDR), and the epidemiological data harmonization and analysis were completed at the International Agency for Research on Cancer (IARC). This study was supported by National Institute of Dental and Craniofacial Research (NIDCR) with direct funding to CIDR.

pht005774.v1.p1

1 Itemgruppe 5 Datenelemente

pht005775.v1.p1

1 Itemgruppe 8 Datenelemente

Eligibility

1 Itemgruppe 1 Datenelement

pht005776.v1.p1

1 Itemgruppe 6 Datenelemente

Eligibility Recurrent Head and Neck Cancer NCT02289209

- 27.06.19 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Reirradiation With MK-3475 in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT02289209

Head and Neck Cancer NCT00265941 Follow-Up - Follow-up Head and Neck Cancer RTOG-0522 F1 NCT00265941

- 05.02.19 - 1 Formular, 8 Itemgruppen, 66 Datenelemente, 1 Sprache
Itemgruppen: Header, CURRENT DISEASE STATUS AND METHOD OF DETERMINATION, DISEASE EVENTS, New primary cancer, Non-Protocol Therapy, Swallowing and Tube Feeding, Protocol Specific Adverse Event Evaluation, Other Adverse Events
RTOG-0522 F1: Follow-up Form Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00265941 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F65D686D-87BE-6280-E034-0003BA3F9857

Eligibility Squamous Head and Neck Cancer NCT01283178

- 14.09.18 - 1 Formular, 2 Itemgruppen, 17 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC; ODM derived from: https://clinicaltrials.gov/show/NCT01283178 Sponsor: Virginia Commonwealth University Collaborator: National Cancer Institute (NCI) Principal Investigator: Shiyu Song Virginia Commonwealth University

Initial Evaluation Oropharyngeal Cancer RTOG 1016 I1NCT01302834

- 04.08.15 - 1 Formular, 11 Itemgruppen, 85 Datenelemente, 1 Sprache
Itemgruppen: Header Module, Patient demographics, Tumor Measurements At Presentation, Basis of Diagnosis, Laboratory Values, Primary Site, Staging, PRIOR TREATMENT, SEVERE ACTIVE COMORBIDITIES, Protocol Specific Adverse Event Evaluation: Use the CTC AE version 4 (MedDRA 12) to code all events., Footer Module
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=94417A43-2D71-18EF-E040-BB89AD432749

Initial Evaluation recurrent Head and Neck Cancer RTOG NCT00113399

- 20.09.21 - 1 Formular, 2 Itemgruppen, 69 Datenelemente, 1 Sprache
Itemgruppen: Header, COMMENTS
Radiation Therapy Oncology Group Follow-up Form Phase III Recurrent Head and Neck Study Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EC4F6FCB-F88D-02BE-E034-0003BA3F9857

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video